{
    "Trade/Device Name(s)": [
        "Ascensia\u00ae CONTOUR\u00ae Blood Glucose Monitoring System (modified test strip)"
    ],
    "Submitter Information": "Bayer HealthCare, Diabetes Care Division",
    "510(k) Number": "K060470",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023657"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "April 12, 2006",
    "Summary Letter Received Date": "February 23, 2006",
    "Submission Date": "February 22, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Capillary Whole Blood",
        "Venous Whole Blood",
        "Arterial Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Ascensia\u00ae CONTOUR\u00ae Blood Glucose Monitoring System meter"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose dehydrogenase enzymatic method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Ascensia\u00ae CONTOUR\u00ae Blood Glucose Monitoring System (modified test strip) for glucose measurement in whole blood.",
    "Indications for Use Summary": "For the measurement of glucose in whole blood; intended for over-the-counter use by persons with diabetes and by healthcare professionals in home and healthcare settings using capillary, venous, or arterial whole blood samples.",
    "fda_folder": "Clinical Chemistry"
}